Daily Movers

Biopharma stocks with notable intraday and pre-market price action.

Movers updated 2026-05-21 13:21 ET

You’re not logged in. Log in to save notes, access full catalyst details, and unlock the complete BPIQ experience.

Daily Movers

Biopharma stocks with significant price action

TickerPriceChangeVolumeMkt CapLatest News
CRBP

Corbus Pharmaceuticals Holdings, Inc.

$11.26+15.72%402K$207.5MCorbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
VXRT

Vaxart, Inc.

$0.70+14.75%120.2K$169.4MNo headline
OKUR

OnKure Therapeutics, Inc.

$4.05+13.76%212.9K$163.6MNo headline
ABCL

AbCellera Biologics Inc.

$5.18+13.35%10.8M$1.6BNo headline
FATE

Fate Therapeutics, Inc.

$2.07+12.50%2.9M$241.3MFate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
RLAY

Relay Therapeutics, Inc.

$14.60+12.14%6.1M$2.8BRelay Therapeutics Announces Pricing of Public Offering of Common Stock
GALT

Galectin Therapeutics Inc.

$2.46+11.31%198.2K$162.0MNo headline
CMPS

COMPASS Pathways plc

$11.98+10.17%3.4M$1.6BNo headline
HUMA

Humacyte, Inc.

$1.00+9.60%4M$223.1MNo headline
KRRO

Korro Bio, Inc.

$10.96+9.49%107.4K$157.8MNo headline
NKTX

Nkarta, Inc.

$3.06+9.29%355.2K$218.2MNo headline
CABA

Cabaletta Bio, Inc.

$3.70+7.70%2.3M$601.7MNo headline
BHVN

Biohaven Ltd.

$9.53+7.68%1.1M$1.4BNo headline
BMRN

BioMarin Pharmaceutical Inc.

$54.05+7.67%2.1M$10.4BBioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia
SGMT

Sagimet Biosciences Inc.

$7.16+7.67%356.2K$439.7MNo headline
KURA

Kura Oncology, Inc.

$11.11+7.45%3.1M$986.3MNo headline
NERV

Minerva Neurosciences, Inc.

$5.39+7.26%80.5K$251.3MNo headline
DFTX

Definium Therapeutics, Inc.

$22.34+7.04%990.5K$2.4BDefinium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
CCCC

C4 Therapeutics, Inc.

$3.51+6.86%1.1M$387.5MNo headline
ZURA

Zura Bio Limited

$4.36+6.73%387.5K$413.7MNo headline